Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: A collaborative children's oncology group/National Cancer Institute Pilot Trial (CCG-1942)
Document Type
Journal Article
Publication Date
2007
Journal
Pediatric Blood & Cancer
Volume
49
Issue
3
Inclusive Pages
250-255
APA Citation
Jacobs, S. (2007). Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: A collaborative children's oncology group/National Cancer Institute Pilot Trial (CCG-1942). Pediatric Blood & Cancer, 49 (3). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/4679
COinS